EORTC led intergroup trial investigates Imatinib failure-free survival in patients with GIST

EORTC trial 62024 results will be presented at ASCO 2013

2013-05-29

(Press-News.org) Interim results of an EORTC intergroup trial have confirmed that adjuvant imatinib impacts short-term freedom from relapse in patients with localized, surgically resected, high/ intermediate-risk GIST. In the high-risk subgroup, a non-statistically significant trend in favor of the adjuvant arm was observed in terms of Imatinib failure-free survival. This new endpoint for the adjuvant setting, survival free from any failure of the first employed tyrosine kinase inhibitor, was designed to incorporate secondary resistance, currently the main factor adversely affecting prognosis of patients with advanced GIST.

Standard treatment for patients with gastrointestinal stromal tumors (GIST), sarcomas of the gastrointestinal wall, is surgery. Neither chemotherapy nor radiation therapy work well for these patients, but EORTC trials had shown that a targeted therapy, the tyrosine kinase inhibitor Imatinib (known as Glivec® in Europe and GleevecTM in the US), is effective in treating patients with advanced GIST. The intergroup randomized controlled phase III EORTC 62024 trial, then, took the logical next step of determining whether Imatinib would also be effective as an adjuvant to surgery in patients with local disease.

Originally, the primary endpoint for this trial was overall survival; relapse-free survival, relapse-free interval, and toxicity were secondary endpoints. In 2009, however, the Independent Data Monitoring Committee, noting the prognostic improvement of patients with advanced GIST, authorized a change in the primary endpoint to Imatinib failure-free survival. Imatinib failure was defined as the time when treatment with a different tyrosine kinase inhibitor began.

The results of EORTC trial 62024 will be presented Monday, 03 June 2013 at an ASCO 2013 Oral Abstract Session by Dr. Paolo Giovanni Casali of the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan and Coordinator of this study.

Between 2005 and 2008, 908 patients with localized, surgically resected, high/intermediate-risk GIST were randomized to Imatinib (400 mg Imatinib daily, 454 patients) or observational (no further therapy after surgery, 454 patients) treatment arms. A total of 835 patients were eligible.

This planned interim analysis was conducted after the occurrence of 115 events according to the Imatinib failure-free survival primary end-point with a significance level of 1.5%. At a median follow-up of 4.7 years, the 5-year Imatinib failure-free survival was 87% in the Imatinib arm and 84% in the observational arm (HR=0.80, 98.5% CI [0.51; 1.26], p=0.23). At three years, relapse-free survival was 84% in the Imatinib arm and 66% in the observational arm, while at five years relapse-free survival was 69% in the Imatinib arm and 63% in the observational arm (p END

ELSE PRESS RELEASES FROM THIS DATE:

Flexible opals

2013-05-29

Instead of through pigments, these 'polymer opals' get their colour from their internal structure alone, resulting in pure colour which does not run or fade. The materials could be used to replace the toxic dyes used in the textile industry, or as a security application, making banknotes harder to forge. Additionally, the thin, flexible material changes colour when force is exerted on it, which could have potential use in sensing applications by indicating the amount of strain placed on the material. The most intense colours in nature - such as those in butterfly wings, ...

New research finds hernia surgery offers value for money

2013-05-29

New research suggesting that elective hernia surgery offers value-for-money and improved quality of life for patients has been published by the Journal of the Royal Society of Medicine. The new analysis is based on patients' own assessments of their health-related quality of life together with costs reported by hospitals. The research also indicates that keyhole surgery may offer more health benefit and value for money than open surgery for hernia operations. Recently it has been suggested that the NHS could save money by reducing access to hernia repair surgery. An inguinal ...

Results of the 'Global Research Council' in Berlin announced

2013-05-29

This news release is available in German. On 29 May 2013, the 2nd Annual Global Meeting of the Global Research Council (GRC) in Berlin has ended. Over three days, the heads of about 70 science and research councils from around the world as well as high-ranking guests from science and research, science administration and research policy attended the meeting. The topics of discussion and endorsement were an Action Plan towards Open Access, a high-level Statement of Principles for Research Integrity as well as new statutes for the GRC. Hosted jointly by the German Research ...

NRL geochemistry survey at Chatham Rise reveals absence of modern day greenhouse gas emissions

2013-05-29

WASHINGTON--Geochemistry analysis conducted by the U.S. Naval Research Laboratory of fossil sediment injection structures off the New Zealand coast in February and March, reveal no presence of modern day expulsions of methane gas, a potential contributor to global 'greenhouse effect' warming. The main focus of this most recent expedition was to investigate the geological origin of seafloor anomalies discovered during a 2007 marine-life survey on the Chatham Rise. During the 2007 survey scientists discovered several large sea floor craters, or pockmarks, including a ...

Coupled particles cross energy wall

2013-05-29

For the first time, a new kind of so-called Klein tunnelling—representing the quantum equivalent of crossing an energy wall— has been presented in a model of two interacting particles. This work by Stefano Longhi and Giuseppe Della Valle from the Institute of Photonics and Nanotechnology in Milan, Italy, is about to be published in EPJ B. Klein tunnelling is a quantum phenomenon referring to the fact that a high-potential barrier can be transparent to a particle moving at a speed nearing that of light, referred to as relativistic. Most of the previous Klein tunnelling ...

Walking or bicycling to work influenced by others

2013-05-29

People who walk or bike to work are likely to influence their co-workers and partners to do the same, according to health researchers. "Social influences are important, specifically interpersonal influences, such as spouses and co-workers," said Melissa Bopp, assistant professor of kinesiology, Penn State. She emphasized that community and employers also significantly influence whether people choose to actively commute. More than 80 percent of American adults do not meet the guidelines for aerobic and muscle-strengthening activities, according to Healthy People 2020, ...

Nanomedicines' impact on patients under the microscope

2013-05-29

A pioneering imaging technique to track the effects of next-generation nanomedicines on patients has been harnessed by a University of Strathclyde academic. Professor Dr. M. N. V. Ravi Kumar and Dr. Dimitrios Lamprou, of the Strathclyde Institute of Pharmacy and Biomedical Sciences, believe an advanced form of atomic force microscopy, known as PeakForce QNM, could boost developments in the field of nanomedicines, the encapsulation of potent drugs in tiny particles measuring billionths of a meter in diameter. They described how this detailed imaging approach may also help ...

Want to move up at work? Be a true believer

2013-05-29

New research is tweaking an old adage about how to get ahead in a competitive workplace: It's not just who you know, but what you believe in. A recently published BYU business study finds that employees who are "true believers" in the mission of their organization are more likely to increase in status and influence than non-believers. "Many organizations today have a well-defined mission with enduring principles that matter, not only to employees, but to other stakeholders," said John Bingham, BYU professor of organizational leadership and strategy. "It's a shift from ...

A molecular chain reaction in Alzheimer's disease

2013-05-29

Researchers at Lund University in Sweden have identified the molecular mechanism behind the transformation of one of the components in Alzheimer's disease. They identified the crucial step leading to formations that kill brain cells. Alzheimer's disease is associated with memory a loss and personality changes. It is still not known what causes the onset of the disease, but once started it cannot be stopped. The accumulation of plaques in the brain is widely considered a hallmark of the disease. The key discovery identified the chemical reaction that causes the plaques ...

Childhood abuse linked with food addiction in adult women

2013-05-29

Women who experienced severe physical or sexual abuse during childhood are much more likely to have a food addiction as adults than women who did not experience such abuse, according to a new study published in the journal Obesity. The study's findings provide valuable new information regarding potential causes and treatments for food addiction and obesity. National surveys indicate that more than a third of American women experienced some form of physical or sexual abuse before they reached 18 years of age. Also, research shows that such childhood abuse has consequences ...

EORTC led intergroup trial investigates Imatinib failure-free survival in patients with GIST

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: